Atea
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atea and other ETFs, options, and stocks.About AVIR
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.
CEOJean-Pierre Sommadossi
CEOJean-Pierre Sommadossi
Employees56
Employees56
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2012
Founded2012
Employees56
Employees56
AVIR Key Statistics
Market cap330.48M
Market cap330.48M
Price-Earnings ratio-2.20
Price-Earnings ratio-2.20
Dividend yield—
Dividend yield—
Average volume646.24K
Average volume646.24K
High today$4.31
High today$4.31
Low today$3.84
Low today$3.84
Open price$3.96
Open price$3.96
Volume1.10M
Volume1.10M
52 Week high$4.34
52 Week high$4.34
52 Week low$2.46
52 Week low$2.46
Stock Snapshot
The current Atea(AVIR) stock price is $4.24, with a market capitalization of 330.48M. The stock trades at a price-to-earnings (P/E) ratio of -2.20.
During the trading session on 2026-01-30, Atea(AVIR) shares reached a daily high of $4.31 and a low of $3.84. At a current price of $4.24, the stock is +10.4% higher than the low and still -1.5% under the high.
Trading activity shows a volume of 1.1M, compared to an average daily volume of 646.24K.
Over the past 52 weeks, Atea(AVIR) stock has traded between a high of $4.34 and a low of $2.46.
Over the past 52 weeks, Atea(AVIR) stock has traded between a high of $4.34 and a low of $2.46.
People also own
Based on the portfolios of people who own AVIR. This list is generated using Robinhood data, and it’s not a recommendation.